Though DPP-4is such as linagliptin do not possess the ability to cross the BBB, they are still proven to possess neuroprotective effects, especially in Alzheimer’s disease, by increasing the bioactivity of GLP-1, which is effective in penetrating the BBB [48]. The gene discussed is GLP1R; the disease is Alzheimer disease.